Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Army
Cipla
Accenture
AstraZeneca
Boehringer Ingelheim
Dow
Teva
Colorcon
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

ROBENGATOPE Drug Profile

« Back to Dashboard

Which patents cover Robengatope, and what generic alternatives are available?

Robengatope is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ROBENGATOPE is rose bengal sodium i-131. There are one hundred and one drug master file entries for this compound. Additional details are available on the rose bengal sodium i-131 profile page.
Summary for ROBENGATOPE
Drug patent expirations by year for ROBENGATOPE
Medical Subject Heading (MeSH) Categories for ROBENGATOPE

US Patents and Regulatory Information for ROBENGATOPE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Accenture
Dow
Moodys
Julphar
Colorcon
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot